scholarly journals Association between Selective Serotonin Reuptake Inhibitors Use and Colorectal Cancer in a Case- Control Study

2019 ◽  
Vol 53 (2) ◽  
pp. 325-329
Author(s):  
Shih-Wei Lai ◽  
Cheng-Li Lin ◽  
Kuan-Fu Liao
Keyword(s):  
Colorectal Cancer ◽  
Serotonin Reuptake ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Case Control Study ◽  
Case Control ◽  
Serotonin Reuptake Inhibitors ◽  
Selective Serotonin ◽  
Control Study

scholarly journals Selective Serotonin Reuptake Inhibitors and Gastrointestinal Bleeding: A Case-Control Study

PLoS ONE ◽  
2011 ◽  
Vol 6 (5) ◽  
pp. e19819 ◽  
Author(s):  
Alfonso Carvajal ◽  
Sara Ortega ◽  
Lourdes Del Olmo ◽  
Xavier Vidal ◽  
Carmelo Aguirre ◽  
...  
Keyword(s):  
Gastrointestinal Bleeding ◽  
Serotonin Reuptake ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Case Control Study ◽  
Case Control ◽  
Serotonin Reuptake Inhibitors ◽  
Selective Serotonin ◽  
Control Study

scholarly journals Case–Control Study Investigating the Association Between Use of Selective Serotonin Reuptake Inhibitors and Pulmonary Tuberculosis in Taiwan

Dose-Response ◽  
2019 ◽  
Vol 17 (4) ◽  
pp. 155932581989716
Author(s):  
Kao-Chi Cheng ◽  
Kuan-Fu Liao ◽  
Cheng-Li Lin ◽  
Shih-Wei Lai
Keyword(s):  
Pulmonary Tuberculosis ◽  
Serotonin Reuptake ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Case Control Study ◽  
Case Control ◽  
Serotonin Reuptake Inhibitors ◽  
Selective Serotonin ◽  
Dependent Effect ◽  
Cumulative Duration ◽  
Control Study

Background and Objective: The aim of the study was to investigate whether use of selective serotonin reuptake inhibitors (SSRIs) was associated with pulmonary tuberculosis. Methods: The case–control study was conducted to analyze the database between 2000 and 2013. Patients aged 20 to 84 years with newly diagnosed pulmonary tuberculosis were selected as the cases (n = 8593). Participants without pulmonary tuberculosis were selected as the controls (n = 43 472). Patients who never had a prescription for SSRIs were defined as never use. Those who ever had a prescription for SSRIs were defined as ever use. Results: The adjusted odds ratio (OR) of pulmonary tuberculosis was 1.03 for patients with ever use of SSRIs (95% confidence interval [CI]: 0.93-1.14), compared to never use. The adjusted OR of pulmonary tuberculosis was 1.00 for patients with increasing cumulative duration of SSRI use for every 1 month (95% CI: 0.99-1.00), compared to never use. The adjusted OR of pulmonary tuberculosis was 0.99 for patients with increasing cumulative dosage of SSRI use for every 1 mg (95% CI: 0.99-1.00), compared to never use. Conclusion: No significant association can be detected between SSRI use and pulmonary tuberculosis in Taiwan. No duration-dependent effect or dose-dependent effect of SSRIs use can be detected on the risk of pulmonary tuberculosis.

Sign in / Sign up

Export Citation Format

Share Document